Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-κB activation in macrophages  by Yu, Honghui et al.
Biochimica et Biophysica Acta 1823 (2012) 1192–1198
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrScavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-κB
activation in macrophages☆
Honghui Yu a,b, Tuanzhu Ha a, Li Liu c, Xiaohui Wang a, Ming Gao a, Jim Kelley d, Race Kao a,
David Williams a, Chuanfu Li a,⁎
a Department of Surgery, James Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA
b Department of Anesthesiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China
c Department of Geriatrics, The First Afﬁliated Hospital of Nanjing Medical University, Nanjing 210029, China
d Department of Internal Medicine, James Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA☆ This work was supported, in part, by NIH HL071837
and D.L.W., NIH GM53552 to D.L.W., NIH GM093878 to
⁎ Corresponding author at: Department of Surgery, E
Campus Box 70575, Johnson City, TN 37614-0575, USA. T
423 439 6259.
E-mail address: Li@ETSU.EDU (C. Li).
0167-4889/$ – see front matter © 2012 Elsevier B.V. Al
doi:10.1016/j.bbamcr.2012.05.004a b s t r a c ta r t i c l e i n f oArticle history:
Received 4 April 2012
Received in revised form 5 May 2012
Accepted 8 May 2012






NF-κBRecent evidence suggests that the macrophage scavenger receptor class A (SR-A, aka, CD204) plays a role in the
induction of innate immune and inﬂammatory responses. We investigated whether SR-A will cooperate with
Toll-like receptors (TLRs) in response to TLR ligand stimulation. Macrophages (J774/a) were treated with
Pam2CSK4, (TLR2 ligand), Polyinosinic:polycytidylic acid (Poly I:C) (TLR3 ligand), and Lipopolysaccharides (LPS)
(TLR4 ligand) for 15 min in the presence or absence of fucoidan (the SR-A ligand). The levels of phosphorylated
IκBα (p-IκBα) were examined by Western blot. We observed that Poly I:C and LPS alone, but not Pam2CSK4 or
fucoidan increased the levels of p-IκBα. However, LPS-induced increases in p-IκBα levels were further enhanced
when presence of the fucoidan. Immunoprecipitation and doubleﬂuorescent staining showed that LPS stimulation
promotes SR-A association with TLR4 in the presence of fucoidan. To further conﬁrm our observation, we isolated
peritoneal macrophages from SR-A deﬁcient (SR-A−/−), TLR4−/− andwild type (WT)mice, respectively. The peri-
toneal macrophages were treated with LPS for 15 min in the presence and absence of fucoidan. We observed that
LPS-stimulated TNFα and IL-1β production was further enhanced in the WT macrophages, but did not in either
TLR4−/− or SR-A−/− macrophages, when fucoidan was present. Similarly, in the presence of fucoidan, LPS-
induced IκBα phosphorylation, NF-κB binding activity, and association between TLR4 and SR-A were signiﬁcantly
enhanced inWTmacrophages comparedwith LPS stimulation alone. Thedata suggests that SR-A is needed for LPS-
induced inﬂammatory responses in macrophages.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Toll-like receptors (TLRs) play an important role in the regulation
of innate immune and inﬂammatory responses by recognition of
pathogen associated molecular patterns (PAMPs) that are not present
in the host [1]. To date, more than ten TLRs have been identiﬁed in
mammals [1]. TLRs recognize cell wall products from various patho-
gens and transduce an activation signal into the cell [1]. TLRs (TLR1,
TLR2, TLR4, TLR5 and TLR6), which are expressed on the cell surface
are involved in the recognition of structures unique to bacteria or
fungi, while TLRs that are localized in intracellular compartments
(TLR3, TLR7, TLR8, and TLR9) recognize viral or bacterial nucleic
acids. After recognition of PAMPs, TLR-mediated cellular signalingto C.L., NIH GM083016 to C.L.
RLK.
ast Tennessee State University,
el.: +1 423 439 6349; fax: +1
l rights reserved.predominately activates NF-κB which is an important transfection
factor regulating a group of gene expression involved in innate im-
mune and inﬂammatory responses [1].
The macrophage scavenger receptor class A (SR-A, aka CD204) was
initially discovered due to its ability to bind and internalize modiﬁed
low-density lipoprotein by macrophages [10,16,32]. Subsequently, nu-
merous studies have reported that SR-A can recognize and clear modi-
ﬁed host components, apoptotic cells, and pathogens [11]. Recent
evidence suggests that SR-A plays a critical role in the induction of in-
nate immune and inﬂammatory responses by recognition of exogenous
PAMPs and endogenous ligands [7]. However, the mechanisms by
which SR-A may regulate the innate immune and inﬂammatory re-
sponses have not been entirely elucidated.
It is well known that both SR-A and TLR4 express on the cell sur-
face of macrophages and dendritic cells [16,27,30,32]. Recent studies
have reported that there is an interaction between SR-A and TLR4 in
response to microbial challenge [3,5,23,31]. For example, SR-A acts
as a co-receptor for TLRs to facilitate innate immune recognition
and response, resulting in an over exuberant response [28]. On the
other hand, TLR ligands synergize with SR-A to mediate bacterial
1193H. Yu et al. / Biochimica et Biophysica Acta 1823 (2012) 1192–1198phagocytosis [2], induce SR-A expression [31], and promote SR-A
binding to LPS which is the TLR4 ligand [31]. However, it is still
unclear whether SR-A is required for TLR ligand-induced inﬂamma-
tory responses.
In the present study, we examined whether SR-A plays a role in
LPS-induced inﬂammatory response in macrophages. We observed
that LPS-induced NF-κB activation and inﬂammatory cytokine pro-
duction were signiﬁcantly enhanced in the wild type macrophages
when fucoidan, the SR-A ligand, was present. In the absence of SR-
A, LPS-stimulated NF-κB binding activity and inﬂammatory cytokine
production were signiﬁcantly reduced. The data suggests that SR-A
is required for LPS-induced inﬂammatory response through TLR4-
mediated NF-κB activation pathway.
2. Materials and methods
2.1. Animal
Breeding pairs of SR-A−/− mice on the C57BL/6J background were
provided by Dr. Siamon Gordon, Sir William Dunn School of Pathology,
Oxford University [6,21]. A small breeding colony was established at
East Tennessee State University (ETSU). The TLR4−/− mice (C57BL/
10ScCr) and wild type (WT, C57BL/10ScSn) mice were obtained from
Jackson Laboratory (Bar Harbor, ME) as described previously [15].
Mice weremaintained and or bred in the Division of Laboratory Animal
Resources at ETSU. The experiments outlined in this manuscript con-
form to the Guide for the Care and Use of Laboratory Animals published
by the National Institutes of Health (NIH Publication No. 85-23, revised
1996). The animal care and experimental protocols for this study were
approved by the ETSU Committee on Animal Care.
2.2. Cell culture and treatment
The murine macrophage cell line J774 A.1 was obtained from
ATCC (ATCC, Manassas, VA, USA). The cells were cultured at 37 °C
in a humidiﬁed incubator (95% air with 5% CO2) in RPMI-1640 me-
dium with 10% fetal bovine serum (FBS), 10 U/ml penicillin and
10 mg/ml streptomycin. Cells (2×106/ml) were cultured in
100 mm tissue culture dishes in RPMI-1640 medium overnight and
treated with fucoidan (50 μg/ml, Sigma, St. Louis, MO), Pam2CSK4
(10 ng/ml, InvivoGen, San Diego, CA), Poly I: C (1 μg/ml, InvivoGen),
and LPS (1 μg/ml, from Escherichia coli 055:B5, Catalog No: L6529,
Sigma), respectively, for the indicated times. The cells were
harvested for isolation of the nuclear and cytoplasmic proteins as
described previously [12,18].
We also isolated peritoneal macrophages from WT and SR-A−/−
and TLR4−/− mice. Brieﬂy, thioglycollate-elicited peritoneal macro-
phages were prepared by using a standard protocol [9]. In brief,
the mice were injected intraperitoneally with 1.5 ml of 3% sterile
Brewer thioglycollate medium (Becton-Dickinson Microbiology Sys-
tems, Sparks, MD). Three days after injection, macrophages were
harvested from the peritoneal cavity by lavaging sterile phosphate
buffered saline. The macrophages were centrifuged at 400 ×g for
10 min resuspended in RPMI 1640 medium supplemented with
10% fetal calf serum, streptomycin (0.1 mg/ml), and penicillin
(100 U/ml). The cells (2×106/ml) were cultured in 100 mm tissue
culture dishes (Corning, Inc, Corning, NY) for 2 h at 37 °C in a hu-
midiﬁed incubator with 5% CO2. After rinsing with PBS, adherent
macrophages were cultured in RPMI 1640 medium at 37 °C with
5% CO2 overnight. The cells were treated with fucoidan (50 μg/ml),
and LPS (1 μg/ml), respectively, for the indicated times. There
were 3 replicates in each group. The cells were harvested and the
nuclear and cytoplasmic proteins were isolated as described previ-
ously [12,18]. The supernatants were collected for analysis of in-
ﬂammatory cytokines (TNF-α and IL-1β).2.3. Western blot
Western blot was performed as described previously [12,17–19].
Brieﬂy, the cellular proteins were separated by SDS-PAGE and trans-
ferred onto Hybond ECL membranes (Amersham Biosciences, Amer-
sham place, Little Chalfon, England). The ECL membranes were
incubated with the appropriate primary antibody (anti-phospho-
IκBα, anti-IκBα (Cell Signaling Technology Inc. Beverly, MA), anti-
TLR4 (a gift from Dr. Ruslan Medzhitov at Yale University) and anti-
SR-A (Santa Cruz Biotechnology, Santa Cruz, CA), respectively,
followed by incubation with peroxidase-conjugated secondary Abs
(Cell Signaling Technology). The same membranes were probed
with anti-GAPDH (BioDesign, Saco, ME) after being washed with
stripping buffer. The signals were detected and quantiﬁed with a G:
Box system (Syngene, Frederick, MD).2.4. Immunoprecipitation
Immunoprecipitation was performed as described previously
[12,18]. Brieﬂy, approximately 800 μg of cellular proteins was immu-
noprecipitated with 2 μg of antibody to SR-A (Santa Cruz Biotechnol-
ogy) for 1 h at 4 °C followed by the addition of 20 μl of protein A/G-
agarose beads (Santa Cruz Biotechnology). The precipitates were
washed four times with lysis buffer and subjected to immunoblotting
with anti-TLR4 and anti-SR-A antibodies, respectively [12,18].2.5. Electrophoretic mobility shift assay (EMSA)
Nuclear proteins were isolated from heart samples as previously
described [12,15,18]. NF-κB binding activity was examined by Light
Shift Chemiluminescent EMSA kit (Thermo Scientiﬁc) according to
the instructions of the manufacturer.2.6. ELISA
The levels of inﬂammatory cytokines; TNFα and IL-1β, were mea-
sured in the supernatants from cultured peritoneal macrophages
using commercially available ELISA kits (PeproTech, Rocky Hill, NJ)
according to the instructions provided by the manufacturer.2.7. Double ﬂuorescent staining
Macrophages were incubated with blocking buffer prior to incuba-
tion with a speciﬁc anti-SR-A (from goat, 1:100, Santa Cruz, CA) at
4 °C overnight. After washing, the cells were incubated with Alexa
555 conjugated anti-goat IgG (1:100, GeneTex, San Antonio, TX) for
1 h at 25 °C. The cells were washed again before incubation with
anti-TLR4 (rabbit, 1:100, a gift from Dr. Ruslan Medzhitov at Yale Uni-
versity) at 4 °C overnight. After washing, the cells were incubated
with FITC conjugated anti-rabbit (1:100, GeneTex, San Antonio, TX)
for 1 h at 25 °C. The cells were covered with ﬂuorescence mounting
medium (Vector labs, Burlingame, CA). Images were captured with
an EVOS digital inverted ﬂuorescence microscope (Advanced Micros-
copy Group. Bothell, WA).2.8. Statistical analysis
Data are expressed as mean±SE. Comparisons of data between
groups were made using one-way analysis of variance, and Tukey's
procedure for multiple range tests was performed. Pb0.05 was con-
sidered signiﬁcant.
Fig. 1. A. Fucoidan, the SR-A ligand, enhanced LPS-induced IκBα phosphorylation in macrophages. Macrophages (J774a.1) were treated with LPS (1 μg/ml), Poly I:C (1 μg/ml),
Pam2CSK4 (10 ng/ml) and fucoidan (50 μg/ml), individually and in combinations as shown, for 15 min. Cells were harvested and the cytoplasmic proteins were prepared for West-
ern blot analysis of IκBα phosphorylation. There were three replicates in each group. A representative Western blot is shown above the graph. *Pb0.05 compared with indicated
groups. B. Fucoidan enhanced LPS-induced IκBα phosphorylation in macrophages in a time dependent manner. Macrophages (J774 A.1) were stimulated with LPS (1 μg/ml) and/or
fucoidan (50 μg/ml), for 15, 30, and 60 min, respectively. Cells were harvested and the cytoplasmic proteins were isolated for analysis of IκBα phosphorylation by Western blot.
There were three replicates in each group. A representative Western blot is shown above the graph. *Pb0.05 compared with indicated groups. C = control, F = fucoidan, L =
LPS, and FL = fucoidan+LPS.
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3.1. Fucoidan treatment enhances LPS-induced IκBα phosphorylation
in macrophages
Recent studies have shown that there is a cooperative effect of
scavenger receptors and TLRs on the response to the stimulation
with PAMPs [7]. We examined whether SR-A will be required for
TLR ligand-induced NF-κB activation. IκBα phosphorylation is the
ﬁrst step for NF-κB nuclear translocation and activation of inﬂamma-
tory gene expression [1], therefore, we examined IκBα phosphoryla-
tion (p-IκBα) as an indicator for NF-κB activation. The macrophage
cell line J774a.1 was treated with Pam2CSK4 (TLR2 ligand), Poly I:C
(TLR3 ligand) and LPS (TLR4 ligand), respectively, in the presence
and absence of fucoidan (SR-A ligand). IκBα phosphorylation wasFig. 2. Fucoidan enhanced LPS-induced association between SR-A and TLR4 in macrophages
fucoidan+LPS, respectively, for 15 min. Cells were harvested and cellular proteins were im
ﬂuorescent staining shows the co-localization of SR-A and TLR4 (B). There were three replica
the graph. *Pb0.05 compared with indicated groups. C = control, F = fucoidan, L = LPS, aexamined. As shown in Fig. 1A, Poly I:C and LPS, but not Pam2CSK4,
signiﬁcantly increased the levels of p-IκBα, respectively, compared
with untreated control. Fucoidan treatment alone did not induce
IκBα phosphorylation in J774a.1 cells. Interestingly, LPS-induced
IκBα phosphorylation was signiﬁcantly enhanced when fucoidan
was present. However, fucoidan treatment did not affect IκBα phos-
phorylation in the macrophages treated with either Poly I:C or
Pam2CSK4. The data suggests that fucoidan synergizes with LPS to
enhance NF-κB activation.
3.2. Fucoidan enhances LPS-induced IκBα phosphorylation in a
time-dependent manner
Next, we examined whether the synergistic effect of fucoidan on
LPS-induced IκBα phosphorylation is time-dependent. We treated. Macrophages (J774 A.1) were stimulated with LPS (1 μg/ml), fucoidan (50 μg/ml) and
munoprecipitated with anti-SR-A followed by immunoblot with anti-TLR4 (A). Double
tes in each group. Magniﬁcation was 40×. A representative immunoblot is shown above
nd FL = fucoidan+LPS.
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presence and absence of fucoidan and measured IκBα phosphoryla-
tion. Fig. 1B shows that, following LPS stimulation, the levels of p-
IκBα peaked at 15 min (5.7 fold) and gradually decreased but
remained higher than untreated controls at 30 and 60 min after treat-
ment. Treatment of macrophages with fucoidan alone did not increase
the levels of p-IκBα. However, the levels of IκBα phosphorylation in
fucoidan+LPS treated cells were signiﬁcantly higher than that of
LPS treatment alone with the peak response occurring at 15 min. The
data suggests that fucoidan synergistically enhances the effect of LPS
on IκBα phosphorylation in a time-dependent manner.
3.3. Fucoidan enhances LPS-induced co-association of SR-A and TLR4
To explore potential mechanisms, we examined whether there
was an association between SR-A and TLR4 following LPS stimulationFig. 3. Fucoidan enhanced LPS-induced NF-κB activation and co-association of SR-A and TL
A−/− mice, respectively. The cells were stimulated with LPS (1 μg/ml), fucoidan (50 μg/ml
and the nuclear proteins were prepared for Western blot analysis of IκBα phosphorylatio
ciation of SR-A and TLR4 in WT macrophages (C), but not in TLR4−/− (D), or SR-A−/− (E)
respectively, for 15 min. The cells were ﬁxed and subjected to double ﬂuorescent staining
three replicates in each group. *Pb0.05 compared with indicated groups. C = control, F =in the presence or absence of fucoidan. Macrophages were treated
with LPS for 15 min in the presence or absence of fucoidan. The
cells were harvested and the cellular proteins were isolated for im-
munoprecipitation with speciﬁc anti-SR-A followed by immunoblot
with speciﬁc anti-TLR4. Fig. 2A shows that LPS stimulation induced
an association between SR-A and TLR4 as demonstrated by the pres-
ence of TLR4 in SR-A immunoprecipitates. Fucoidan treatment en-
hanced LPS-induced association of SR-A with TLR4 (Fig. 2A). Double
ﬂuorescent staining using speciﬁc antibodies to SR-A and TLR4
showed that there was no detectable co-localization between SR-A
and TLR4 in both untreated control cells and fucoidan-treated cells.
LPS stimulation induced co-localization of SR-A with TLR4 as shown
by the yellow color in the merged double ﬂuorescent staining image
(Fig. 2B). Importantly, in the presence of fucoidan, LPS-induced co-
localization between SR-A and TLR4 was further increased. The data
suggest that presence of fucoidan enhanced LPS-induced IκBαR4 in macrophages. Peritoneal macrophages were isolated from WT, TLR4−/− and SR-
), and fucoidan+LPS, respectively, for 15 min. Cells were harvested. The cytoplasmic
n (A) and NF-κB binding activity by EMSA (B). Fucoidan enhanced LPS-induced asso-
. The cells were treated with LPS (1 μg/ml), fucoidan (50 μg/ml), and fucoidan+LPS,
of co-localization of SR-A (green) and TLR4 (red). Magniﬁcation was 40×. There were
fucoidan, L = LPS, and FL = fucoidan+LPS.
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tween SR-A and TLR4.
3.4. SR-A is required for LPS-induced NF-κB activation in macrophages
To determine whether SR-A is required for the fucoidan-enhanced
LPS-induced NF-κB activation in macrophages, we isolated peritoneal
macrophages from WT, TLR4−/− and SR-A−/− mice, respectively. The
cells were stimulatedwith LPS in the presence and absence of fucoidan.
NF-κB binding activity was measured. Fig. 3 shows that LPS stimulation
increased the levels of p-IκBα (A) andNF-κB binding activity (B) in both
WT and SR-A−/−macrophages comparedwith untreated control. In the
presence of fucoidan, LPS-increased levels of p-IκBα and NF-κB binding
activity were further enhanced inWTmacrophages but not in SR-A−/−
macrophages. LPS or fucoidan treatment alone did not induce increases
in IκBα phosphorylation and NF-κB binding activity in TLR4−/−macro-
phages (Fig. 3A, B). However, the levels of p-IκBα andNF-κB binding ac-
tivity were signiﬁcantly enhanced when the TLR4−/− macrophages
were treatedwith LPS+fucoidan. The data suggests that SR-A is needed
for maximal LPS-induced response in macrophages.
Double ﬂuorescent staining showed that there was no detectable
co-localization of SR-A with TLR4 in both untreated-control and
fucoidan-treated WT macrophages. LPS treatment induced a co-
localization of SR-A with TLR4 in WT macrophages. When fucoidan
was present, LPS-induced co-localization of SR-A and TLR4was further
enhanced (Fig. 3C). There was no detectable co-localization of TLR4
and SR-A in TLR4−/− or SR-A−/− macrophages, as expected, after
treatment with fucoidan, LPS, or LPS+fucoidan (Fig. 3D, E). The data
suggests that fucoidan-enhanced the effect of LPS on NF-κB activation
may be mediated via co-association between SR-A and TLR4.
3.5. Fucoidan synergizes with LPS to increase inﬂammatory cytokine
secretion in macrophages
TLR4-mediated signaling predominantly activates NF-κB which is
an important transcription factor controlling inﬂammatory cytokine
gene expression [1]. We examined whether fucoidan treatment will
enhance LPS-induced inﬂammatory cytokine production. Peritoneal
macrophages were isolated fromWT, TLR4−/− and SR-A−/−mice, re-
spectively and treated with LPS for 24 h in the presence and absence
of fucoidan. The supernatants were harvested and the levels of TNFα
and IL-1β were measured by ELISA kits. As shown in Fig. 4, LPS stim-
ulation increased the secretion of TNFα and IL-1β in WT macro-
phages. In the presence of fucoidan, however, LPS-increased TNFα
and IL-1β production was further enhanced in WT macrophages.
LPS also stimulated production of TNF-α in both TLR4−/− and SR-Fig. 4. SR-A and TLR4 are required for fucoidan-enhanced LPS-induced cytokine production i
mice, respectively. The cells were stimulated with LPS (1 μg/ml), fucoidan (50 μg/ml), and fu
and IL-β production by ELISA. There were three replicates in each group. *Pb0.05 compareA−/− macrophages but the levels were signiﬁcantly lower than that
in WT macrophages. Fucoidan treatment did not enhance LPS-
stimulated production of TNFα and IL-1β in either TLR4−/− or SR-
A−/− macrophages.
4. Discussion
The major ﬁnding in the present study was that SR-A is needed for
LPS-stimulation of NF-κB activation and inﬂammatory cytokine pro-
duction in macrophages. LPS stimulation induced NF-κB activation
and an association of TLR4 with SR-A in WT macrophages which
were further enhanced when the SR-A ligand, fucoidan, was present.
Deﬁciency of either SR-A or TLR4 signiﬁcantly reduced the response
of macrophages to LPS stimulation. These data indicate that presence
of SR-A is an essential for LPS-induced TLR4-mediated NF-κB activa-
tion and inﬂammatory cytokine production in macrophages.
SR-A is a trimeric membrane glycoprotein that is expressed on
macrophages and dendritic cells [11,24,26]. Initial studies have
reported that SR-A expressed on macrophages to bind and internalize
modiﬁed LDL [10]. Recently, SR-A has been shown to mediate phago-
cytosis, promote cell adhesion and recognize several PAMPs, includ-
ing LPS, lipoteichoic acid (LTA), bacterial CpG DNA, double‐stranded
RNA, and yeast zymosan/β-glucans [4,14,20,22,34]. Interestingly,
these PAMPs can also be recognized by TLRs [1], indicating there is
a possible cooperation between SR-A and TLRs in response to the
stimulation with the PAMPs. Indeed, recent studies have shown that
SR-A acts as a pattern recognition receptor (PRR) and cooperates
with other PRRs to facilitate innate immune recognition and inﬂam-
matory responses [14,20,28,34].
In the present study, we observed that stimulation of macro-
phages with the TLR3 ligand, Poly I:C, and the TLR4 ligand, LPS,
signiﬁcantly increased the levels of IκBα phosphorylation. Interest-
ingly, in the presence of fucoidan, the SR-A ligand, TLR4 ligand,
but not TLR2 or TLR3 ligand, induced-IκBα phosphorylation in
macrophages was further enhanced. The data suggests that SR-A
could synergistically cooperate with TLR4 in response to LPS stim-
ulation. Recently, Seimon et al. have reported that SR-A can act co-
operatively with TLR4 to facilitate innate immune recognition and
response [28]. These authors have shown that stimulation of SR-A
with its ligand promotes a TLR4-mediated pro-inﬂammatory and
pro-apoptotic responses in LPS exposed macrophages [28]. SR-A li-
gands trigger apoptosis in endoplasmic reticulum (ER)-stressed
macrophages by cooperating with TLR4 [28]. Other studies have
also shown that stimulation of SR-A resulted in the induction of
innate immune and inﬂammatory responses [14,20,34]. On the
other hand, TLR ligands synergize with SR-A to mediate bacterialn macrophages. Peritoneal macrophages were isolated fromWT, TLR4−/− and SR-A−/−
coidan+LPS, respectively, for 24 h. Supernatants were harvested for analysis of TNF-α
d with indicated groups.
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binding to the TLR4 ligand, LPS [31]. Collectively, these data sug-
gest that SR-A and TLR4 cooperatively stimulate the innate im-
mune and inﬂammatory responses. However, it is unclear how
SR-A cooperates with TLR4 in the induction of innate immune
and inﬂammatory responses.
To address whether SR-A synergistically cooperates with TLR4
in response to LPS stimulation in macrophages, we performed im-
munoprecipitation with anti-SR-A followed by immunoblot with
anti-TLR4. We observed that LPS stimulation alone induced an as-
sociation between SR-A and TLR4 in macrophages as evidenced
by showing the presence of TLR4 in the immunoprecipitation
with anti-SR-A. Importantly, the LPS-induced association of SR-A
with TLR4 was signiﬁcantly greater than that of LPS stimulation
alone when the SR-A ligand, fucoidan, was present. Double ﬂuores-
cent staining showed a consistent result demonstrating increased
co-localization of SR-A with TLR4 following LPS+fucoidan stimula-
tion. The data suggest that the presence of SR-A is essential for
maximal LPS-induced response in macrophages. Indeed, LPS-
induced NF-κB binding activity and inﬂammatory cytokine produc-
tion was further increased in WT macrophages when fucoidan was
present, indicating that SR-A synergistically cooperates with TLR4
in response to LPS stimulation in macrophages. In contrast, SR-A
deﬁciency resulted in signiﬁcantly reduced NF-κB binding activity
and inﬂammatory cytokine production even in the presence of
both LPS and fucoidan, suggesting that SR-A is required for maxi-
mal LPS-induced activation of the TLR4-mediated NF-κB pathway.
At present, we do not understand the mechanisms by which LPS
promoted SR-A interaction with TLR4 when the SR-A ligand was
present. However, recent studies have shown that SR-A interacts
with Mer receptor tyrosine kinase [29] and Lyn kinase [24]. Fong
et al. [8] have reported phosphorylation of SR-A intracellular do-
mains may facilitate the interaction of the SR-A transmembrane
domain with intracellular signaling components. LPS stimulation
also induced TLR4 tyrosine phosphorylation [13,25]. Therefore, it
is possible that tyrosine kinases may be involved in the interaction
between SR-A and TLR4 following their ligand stimulation. Recent-
ly, Yu et al. reported that LPS stimulation of bone marrow dendrit-
ic cells (DCs) induced an interaction between SR-A and TRAF6,
resulting in limiting the response of DCs to LPS stimulation [33].
However, Seimon et al. [28] have shown that stimulation of SR-A
with its ligand promoted activation of the TLR4-mediated NF-κB
pathway in response to LPS stimulation and that SR-A could
serve as a co-receptor for TLR4 in response to LPS challenge. The
difference between our result and those of Yu et al. may reﬂect
differences in cells types and readouts employed.
In summary, the present study has shown that SR-A is essential for
maximal LPS-induced activation of the TLR4-mediated NF-κB signal-
ing pathway in macrophages. Deﬁciency of either SR-A or TLR4 re-
duced the response of macrophages to LPS stimulation. The data
indicates that both SR-A and TLR4 are targets for controlling
endotoxin-induced inﬂammatory responses.Conﬂict of interest
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